THE IMPACT OF DIGITAL THERAPEUTICS (DTX) ON GLYCEMIC CONTROL AND PATIENT QUALITY OF LIFE IN TYPE 2 DIABETES

Article Sidebar

PDF|Download
Published: 2026-03-04
Keywords:
Diabetes Mellitus Type 2, Digital Therapeutics (DTx), Artificial Intelligence in Medicine, Glycemic Control, HbA1c, Swiss Healthcare System, Patient Adherence, mHealth, Precision Medicine.

Main Article Content

Elena Rossi

Abstract

This study, conducted in a Swiss cantonal hospital setting, explores the role of digital health technologies in chronic disease management. The results show that using AI algorithms to monitor diet and medication regimens significantly reduces patients' HbA1c.

Article Details

Issue

Vol. 1 No. 1 (2026): Multidisciplinary Journal of Life Sciences and Medicine.

Section

Articles

References

1. Swiss Medical Weekly. (2024). Digital Health in Chronic Disease Management.

2. The Lancet Diabetes & Endocrinology. (2025). Personalized Medicine in Europe.